Related Experiment Videos
Selection of H-2 molecules for the context of antigen recognition by T lymphocytes
Immunogenetics
|January 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Cytotoxic T-cell precursor frequencies to HER-2 (369-377) in patients with HER-2/neu-positive epithelial tumours.
British journal of cancer·2003
Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants.
Cancer immunology, immunotherapy : CII·2002
Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope.
British journal of cancer·2001
Genetic association of immunosenescence to immune decline.
Immunogenetics·2026